Capricor Therapeutics
CAPR
CAPR
61 hedge funds and large institutions have $30.7M invested in Capricor Therapeutics in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $32.7M → $30.7M (-$2.06M)
26% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $1.84M
Holders
61
Holding in Top 10
–
Calls
$1.36M
Puts
$1.84M
Top Buyers
| 1 | +$5.95M | |
| 2 | +$1.49M | |
| 3 | +$1.36M | |
| 4 |
Millennium Management
New York
|
+$889K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$873K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$689K | |
| 3 | -$622K | |
| 4 |
HF
HRT Financial
New York
|
-$560K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$542K |